These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26114663)

  • 21. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.
    Ghosh J; Pradhan S; Mittal B
    Neuromolecular Med; 2013 Mar; 15(1):61-73. PubMed ID: 22875483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density.
    Chiang TI; Lane HY; Lin CH
    Sci Rep; 2020 Aug; 10(1):13236. PubMed ID: 32764574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.
    Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
    Arch Gen Psychiatry; 2012 Apr; 69(4):339-48. PubMed ID: 22474103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical mediation of relationships between dopamine receptor D2 and cognition is absent in youth at risk of bipolar disorder.
    Overs BJ; Lenroot RK; Roberts G; Green MJ; Toma C; Hadzi-Pavlovic D; Pierce KD; Schofield PR; Mitchell PB; Fullerton JM
    Psychiatry Res Neuroimaging; 2021 Mar; 309():111258. PubMed ID: 33529975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders.
    Wirgenes KV; Sønderby IE; Haukvik UK; Mattingsdal M; Tesli M; Athanasiu L; Sundet K; Røssberg JI; Dale AM; Brown AA; Agartz I; Melle I; Djurovic S; Andreassen OA
    Transl Psychiatry; 2012 May; 2(5):e112. PubMed ID: 22832956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical thickness mediates the relationship between DRD2 C957T polymorphism and executive function across the adult lifespan.
    Miranda GG; Rodrigue KM; Kennedy KM
    Brain Struct Funct; 2021 Jan; 226(1):121-136. PubMed ID: 33179159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
    Oishi K; Kanahara N; Takase M; Oda Y; Nakata Y; Niitsu T; Ishikawa M; Sato Y; Iyo M
    PLoS One; 2018; 13(11):e0207133. PubMed ID: 30408108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.
    Simons CJ; van Winkel R;
    Schizophr Bull; 2013 Jul; 39(4):848-56. PubMed ID: 22532702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine and cognitive control: sex-by-genotype interactions influence the capacity to switch attention.
    Gurvich C; Rossell SL
    Behav Brain Res; 2015 Mar; 281():96-101. PubMed ID: 25510197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.
    McDonell KE; van Wouwe NC; Harrison MB; Wylie SA; Claassen DO
    Brain Behav; 2018 Jul; 8(7):e01008. PubMed ID: 29856137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 receptor gene polymorphisms and externalizing behaviors in children and adolescents.
    Della Torre OH; Paes LA; Henriques TB; de Mello MP; Celeri EHRV; Dalgalarrondo P; Guerra-Júnior G; Santos-Júnior AD
    BMC Med Genet; 2018 May; 19(1):65. PubMed ID: 29716536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report.
    Amir QU; Hanif F; Washdev W; Bilwani F; Usman Simjee S
    Int J Clin Pract; 2020 Sep; 74(9):e13536. PubMed ID: 32420660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis of dopamine D2-like receptor genes and methamphetamine abuse.
    Chen CK; Hu X; Lin SK; Sham PC; Loh el-W; Li T; Murray RM; Ball DM
    Psychiatr Genet; 2004 Dec; 14(4):223-6. PubMed ID: 15564898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
    Nkam I; Ramoz N; Breton F; Mallet J; Gorwood P; Dubertret C
    PLoS One; 2017; 12(1):e0170147. PubMed ID: 28085950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
    [No Abstract]   [Full Text] [Related]  

  • 39. The DRD2 rs1800497 polymorphism increase the risk of mood disorder: evidence from an update meta-analysis.
    Zhang L; Hu L; Li X; Zhang J; Chen B
    J Affect Disord; 2014 Apr; 158():71-7. PubMed ID: 24655768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.
    Failla MD; Myrga JM; Ricker JH; Dixon CE; Conley YP; Wagner AK
    J Head Trauma Rehabil; 2015; 30(6):E54-66. PubMed ID: 25931179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.